Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2.
Hopper
J L
JL
Jenkins
M A
MA
D000328:Adult; D017668:Age of Onset; D000375:Aging; D024682:BRCA2 Protein; D001943:Breast Neoplasms / Q000175:diagnosis / Q000208:ethnology / Q000235:genetics; D005192:Family Health; D005260:Female; D018703:Founder Effect; D019398:Genes, BRCA1 / Q000235:genetics*; D006579:Heterozygote; D006801:Humans; D007585:Jews / Q000235:genetics*; D008297:Male; D008875:Middle Aged; D015233:Models, Statistical; D009154:Mutation / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics*; D010051:Ovarian Neoplasms / Q000175:diagnosis / Q000208:ethnology / Q000235:genetics; D019683:Penetrance; D011336:Probability; D014157:Transcription Factors / Q000235:genetics*
D024682:BRCA2 Protein; D009363:Neoplasm Proteins; D014157:Transcription Factors